Other studies have identified genes from BC clinical samples, such as cyclooxygenase COX2 (also known as PTGS2), the epidermal growth factor receptor (EGFR) ligand HBEGF, and the brain-specific 2,6-sialyltransferase ST6GALNAC5 as mediators of BC cell passage through the BBB 83. This evidence concerns the gene PTGS2 and breast cancer.